Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a retrospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| endovascular treatment | Other | all enrolled patients must receive endovascular treatment. |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of patients with modified Rankin Score (mRS) 0 to 2 | the minimum and maximum values of mRS are 0 and 6, respectively; higher mRS mean a worse outcome | Day 90 |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in National Institute of Health stroke scale (NIHSS) | the minimum and maximum values of NIHSS are 0 and 42, respectively; higher NIHSS mean a worse outcome | Day 2, 7, 14 |
| Proportion of patients with modified Rankin Score 0 to 2 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
all patients must receive endovascular treatment regardless of the time from onset to treatment.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Neurology, General Hospital of Northern Theater Command | Shenyang | 110016 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40947819 | Derived | Xing GP, Li W, Cui C, Zhao ZA, Nguyen TN, Chen HS. Thrombolysis to Recanalization Time Affects the Benefit of Bridging Thrombolysis in Large Vessel Occlusion Patients With Successful Recanalization. CNS Neurosci Ther. 2025 Sep;31(9):e70579. doi: 10.1111/cns.70579. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Proportion of patients with modified Rankin Score 0 to 2
| Day180, 360 |
| Distribution of modified Rankin Score | Distribution of modified Rankin Score after treatment | Day 90, 180, 360 |
| Proportion of symptomatic intracranial hemorrhage (sICH) | sICH was defined as 4 or more increase in NIHSS caused by hemorrhage | 48 hours |
| Proportion of intraparenchymal hemorrhage (PH1 and PH2) | Proportion of intraparenchymal hemorrhage (PH1 and PH2) after treatment | 48 hours |
| Proportion of death | death due to any cause | Day 7 |
| Changes in cerebral edema | edema is determined by middle shift. | 48 hours, 7 days |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |